Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene

Giuseppe Di FedeEmail author View ORCID ID profile,
Marcella Catania,
Cristiana Atzori,
Fabio Moda,
Claudio Pasquali,
Antonio Indaco,
Marina Grisoli,
Marta Zuffi,
Maria Cristina Guaita,
Roberto Testi,
Stefano Taraglio,
Maria Sessa,
Graziano Gusmaroli,
Mariacarmela Spinelli,
Giulia Salzano,
Giuseppe Legname,
Roberto Tarletti,
Laura Godi,
Maurizio Pocchiari,
Fabrizio Tagliavini,
Daniele Imperiale and
Giorgio Giaccone

Acta Neuropathologica Communications20197:1

https://doi.org/10.1186/s40478-018-0656-4

Received: 30 October 2018
Accepted: 21 December 2018
Published: 3 January 2019

Abstract

Prion diseases are neurodegenerative disorders which are caused by an accumulation of the abnormal, misfolded prion protein known as scrapie prion protein (PrPSc). These disorders are unique as they occur as sporadic, genetic and acquired forms. Sporadic Creutzfeldt-Jakob Disease (CJD) is the most common human prion disease, accounting for approximately 85–90% of cases, whereas autosomal dominant genetic forms, due to mutations in the prion protein gene (PRNP), account for 10–15% of cases. Genetic forms show a striking variability in their clinical and neuropathological picture and can sometimes mimic other neurodegenerative diseases.

We report a novel PRNP mutation (V189I) in four CJD patients from three unrelated pedigrees. In three patients, the clinical features were typical for CJD and the diagnosis was pathologically confirmed, while the fourth patient presented with a complex phenotype including rapidly progressive dementia, behavioral abnormalities, ataxia and extrapyramidal features, and the diagnosis was probable CJD by current criteria, on the basis of PrPSc detection in CSF by Real Time Quaking-Induced Conversion assay. In all the three patients with autopsy findings, the neuropathological analysis revealed diffuse synaptic type deposition of proteinase K-resistant prion protein (PrPres), and type 1 PrPres was identified in the brain by western blot analysis. So, the histopathological and biochemical profile associated with the V189I mutation was indistinguishable from the MM1/MV1 subtype of sporadic CJD.

Our findings support a pathogenic role for the V189I PRNP variant, confirm the heterogeneity of the clinical phenotypes associated to PRNP mutations and highlight the importance of PrPSc detection assays as diagnostic tools to unveil prion diseases presenting with atypical phenotypes.